These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25975902)

  • 1. [Antibodies in the immunohistochemical detection of estrogen and progesterone receptor status in breast carcinoma].
    Shui R; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):229-31. PubMed ID: 25975902
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometric steroid receptor analysis.
    Schutte B; Scheres HM; De Goeij AF; Rousch MJ; Blijham GH; Bosman FT; Ramaekers FC
    Prog Histochem Cytochem; 1992; 26(1-4):68-76. PubMed ID: 1484969
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guideline for testing of estrogen and progesterone receptors in breast cancer].
    Guideline Recommendations for Immunohistochemistry Detection in Breast Cancer Group
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):237-9. PubMed ID: 25975904
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
    Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
    Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
    Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
    Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical evaluation of estrogen and progesterone receptors on paraffin sections of breast carcinomas. Practical thoughts based on the study of 368 cases].
    Balaton AJ; Baviera EE; Galet B; Vaury P; Vuong PN
    Arch Anat Cytol Pathol; 1995; 43(1-2):93-100. PubMed ID: 7794034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients.
    Fritz P; Tuczek HV; Offinger B; Schwarzmann P; Schieszl S; Wu X; Kleine B; Blödorn J; Multhaupt H
    Prog Histochem Cytochem; 1992; 26(1-4):146-58. PubMed ID: 1283015
    [No Abstract]   [Full Text] [Related]  

  • 10. Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue.
    Ciocca DR; Stati AO; Amprino de Castro MM
    Breast Cancer Res Treat; 1990 Oct; 16(3):243-51. PubMed ID: 2085675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical comparison between GCDFP-15 and estrogen and progesterone receptors in the diagnosis of metastatic carcinoma of the breast].
    Villarroel Salinas J; Ortiz Hidalgo C; Soria Céspedes D
    Gac Med Mex; 2012; 148(3):213-7. PubMed ID: 22820353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
    Scharl A; Vierbuchen M; Würz H
    Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630
    [No Abstract]   [Full Text] [Related]  

  • 13. pS2 protein and steroid hormone receptors in invasive breast carcinomas.
    Koerner FC; Goldberg DE; Edgerton SM; Schwartz LH
    Int J Cancer; 1992 Sep; 52(2):183-8. PubMed ID: 1521907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.
    Sharangpani GM; Joshi AS; Porter K; Deshpande AS; Keyhani S; Naik GA; Gholap AS; Barsky SH
    J Microsc; 2007 Jun; 226(Pt 3):244-55. PubMed ID: 17535263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma.
    Chu JS; Lee WJ; Chen KM; Hsu HC
    J Formos Med Assoc; 1994 Apr; 93(4):277-82. PubMed ID: 7914767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
    Muchiri LW
    East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual cycle and hormone receptor status in breast cancer patients.
    Atalay C; Kanliöz M; Altinok M
    Neoplasma; 2002; 49(4):278. PubMed ID: 12382029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic targeting in breast cancer].
    Penault-Llorca F
    Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.